Societe Generale acquired a new position in Chemtura Corp. (NYSE:CHMT) during the second quarter, Holdings Channel reports. The firm acquired 18,889 shares of the company’s stock, valued at approximately $498,000.

A number of other large investors have also recently bought and sold shares of CHMT. Prudential Financial Inc. raised its stake in Chemtura Corp. by 0.3% in the first quarter. Prudential Financial Inc. now owns 33,517 shares of the company’s stock worth $885,000 after buying an additional 100 shares in the last quarter. Metropolitan Life Insurance Co. NY raised its stake in Chemtura Corp. by 1.0% in the first quarter. Metropolitan Life Insurance Co. NY now owns 46,667 shares of the company’s stock worth $1,232,000 after buying an additional 472 shares in the last quarter. Alpha Windward LLC raised its stake in Chemtura Corp. by 5.6% in the second quarter. Alpha Windward LLC now owns 15,900 shares of the company’s stock worth $419,000 after buying an additional 840 shares in the last quarter. Kennedy Capital Management Inc. raised its stake in Chemtura Corp. by 0.4% in the first quarter. Kennedy Capital Management Inc. now owns 282,633 shares of the company’s stock worth $7,462,000 after buying an additional 1,022 shares in the last quarter. Finally, BlackRock Inc. raised its stake in Chemtura Corp. by 60.4% in the first quarter. BlackRock Inc. now owns 5,864 shares of the company’s stock worth $155,000 after buying an additional 2,207 shares in the last quarter.

Shares of Chemtura Corp. (NYSE:CHMT) traded down 0.10% on Friday, reaching $30.27. 266,287 shares of the company’s stock were exchanged. The company’s 50 day moving average is $29.23 and its 200-day moving average is $27.26. Chemtura Corp. has a one year low of $23.50 and a one year high of $32.34. The stock has a market cap of $1.91 billion and a price-to-earnings ratio of 57.11.

Chemtura Corp. (NYSE:CHMT) last posted its earnings results on Thursday, July 28th. The company reported $0.40 earnings per share for the quarter, missing analysts’ consensus estimates of $0.46 by $0.06. The company had revenue of $441 million for the quarter, compared to analysts’ expectations of $440.06 million. During the same period in the previous year, the business posted $0.29 earnings per share. The business’s quarterly revenue was down 5.0% compared to the same quarter last year. On average, analysts anticipate that Chemtura Corp. will post $1.77 EPS for the current year.

Separately, Zacks Investment Research downgraded shares of Chemtura Corp. from a “buy” rating to a “hold” rating in a research report on Monday, August 1st. Six equities research analysts have rated the stock with a buy rating, The stock currently has an average rating of “Buy” and an average target price of $33.60.

In related news, VP Dalip Puri sold 900 shares of the firm’s stock in a transaction on Wednesday, August 17th. The shares were sold at an average price of $31.55, for a total value of $28,395.00. Following the completion of the transaction, the vice president now directly owns 12,124 shares of the company’s stock, valued at $382,512.20. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.

Chemtura Corporation is a developer, manufacturer and marketer of engineered industrial specialty chemicals. The Company’s products are sold to industrial manufacturing customers for use as additives, ingredients or intermediates that add value to their end products. It operates through two segments: Industrial Performance Products and Industrial Engineered Products.